Home/Filings/4/0001599901-25-000037
4//SEC Filing

Flanagan W. Michael 4

Accession 0001599901-25-000037

CIK 0001599901other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 8:12 PM ET

Size

8.0 KB

Accession

0001599901-25-000037

Insider Transaction Report

Form 4
Period: 2025-01-21
Flanagan W. Michael
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2025-01-21$28.60/sh3,860$110,38393,787 total
  • Sale

    Common Stock

    2025-01-21$28.59/sh1,812$51,80991,975 total
Footnotes (3)
  • [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on January 20, 2025 and the sale of the resulting shares of common stock on January 21, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the Reporting Person. The Reporting Person has executed an instruction letter for the automatic sale of such "sell-to-cover" shares, intended to satisfy the affirmative defense conditions of Rule 10b5-1.
  • [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.59 to $29.63. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.59 to $28.89. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Avidity Biosciences, Inc.

CIK 0001599901

Entity typeother

Related Parties

1
  • filerCIK 0001841990

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 8:12 PM ET
Size
8.0 KB